Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucarpidase for MTX Clearance in DLBCL
NCT05022797Phase 2Terminated
- Sponsor
- Fundación CRIS contra el Cáncer
- Start
- Jul 2021
- Primary completion
- Nov 2022
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in Methotrexate toxicity, sponsored by Fundación CRIS contra el Cáncer. Started Jul 2021; status: terminated.
02
Drugs
glucarpidase
03
Conditions
Methotrexate toxicity
Beyond the preview
Go deeper on NCT05022797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022797.